![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2420 | Ordered by Region (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
Position |
Organisation (Group) |
 Region |
|---|---|---|---|
| Anglade, Eddy (Tenpoint Therapeutics 202307 CEO) | n. a. | ||
| Antonelli, Pierluigi (Angelini 202103 CEO of Angelini Pharma) | Chief Executive Officer (CEO) | Angelini (Group) | |
| Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) | Chief Executive Officer (CEO) | ||
| Baran, Michael (Pfizer 201912 Principal at Pfizer Ventures + Exec Director External Science + Innovation) | Principal (venture capital) | Pfizer (Group) | |
| Bastid, Pierre | n. a. | ||
| Bissay, Philippe (H.A.C. Pharma 202211 CEO) | Chief Executive Officer (CEO) | H.A.C. Pharma (FR) | |
| Boël, Harold (Sofina 202109 CEO) | Chief Executive Officer (CEO) | ||
| Boman, Sakari (Vital Scientific 200607) | n. a. | Elitech (Group) | |
| Carreel, Eric (Indigo) | n. a. | Indigo (holding company of Eric Carreel) | |
| Chusseau, Maylis (Aquitaine Science Trasfert 201905 President) | technology transfer | ||
| Elliott, Eric (Voluntis 202011 Board Chairman) | n. a. | ||
| Farmer, Edward (202312 PR Consultant) | Public Relations Manager / Investor Relations Manager | OTHER | |
| Forest, Eric (Euronext 201404 CEO at EnterNext) | Chief Executive Officer (CEO) | Euronext (Group) | |
| Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) | Professor | Max Planck Society for the Advancement of Science | |
| Gaiotto, Michele (Zambon 202211 CEO of HTH VC) | Chief Executive Officer (CEO) | Zambon (Group) | |
| Germain, Matthieu (Nanobiotix 201905– CEO of Curadigm) | Chief Executive Officer (CEO) | Nanobiotix (Group) | |
| Gouy, Michel (JSP Partners 201207 Partner) | n. a. | JSB Partners L.P. | |
| Greig, Russell G. (Greig Biotechnology Global Consulting before 30y at GSK most recently President of SR One) | Board member | Greig Biotechnology Global Consulting Inc. | |
| Grinberg-Rashi, Helena (Aido 202209 CEP + Founder) | Chief Executive Officer (CEO) | ||
| Guedj, Jean-Yves (Sanesco 201005 President) | President/Director/Head Business Group/Unit/Division | General Electric (Group) | |
| Kemps, Serge (Nipro 201601 at Nipro Europe) | n. a. | Nipro Corporation (Group) | |
| Kuegler, Klaus (Eurofins 201801 SVP Agroscience Services Group) | President/Director/Head Business Group/Unit/Division | Eurofins (Group) | |
| Kurian, Thomas (Alphabet 201906 CEO of Google Cloud) | n. a. | ||
| Lasocki, Vladimir (Carlyle 202107 Co-Head of Carlyle Europe Technology Partners) | Investment Manager | Carlyle (Group) | |
| Lautner, Christian (Heal Capital 202306 Founding Managing Partner + Eternity.Health 202107 MD + Co-Founder) | Managing Director | Heal Capital (Heal.Capital) (Group) | |
| Ligresti, Antonino (Santé Holding Srl 201509 + Board Director at Abivax 201509–) | Investment Manager | Santé Holding Srl | |
| Munoz, Alain (Sanofi + Fournier) | Research & Development Manager | ||
| Niel, Xavier | n. a. | ||
| Oldfield, Steve (Teva 201506– General Manager UK +IE before Sanofi Managing Director UK+IE) | General Manager (management) | Teva (Group) | |
| Olson, Sara (FMC 202107 Principal at FMC Ventures) | Managing Director | FMC (Group) | |
| Papadopoulos, Stelios (Cowen –200612 retired) | Board member, non-executive | Société Générale (Group) | |
| Pisano, Wayne (Sanofi Pasteur –200801– President + CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | |
| Pomel, Olivier (Datadog 202403 CEO + Co-Founder) | n. a. | ||
| Raybaud, Olivier (SWEN Capital Partners 202309 Managing Director) | Managing Director | SWEN Capital Partners (Group) | |
| Richard, Jean Philippe (France (govt) 201907 Investment Director of SPI Fund of bpifrance) | Investment Manager | France (govt) | |
| Rochlin, Kate (Nanobiotix 201905– Director of Business Development at Curadigm) | Business Development Manager / Strategy Manager | Nanobiotix (Group) | |
| Saarela, Sakari (UB FIGG 202309 Partner) | Partner (venture partner) | United Bankers (UB) (Group) | |
| Sabino, Dora (Blazar 202206 CEO + Co-Founder) | Chief Executive Officer (CEO) | Blazar S.A.S. | |
| Santoro, Lyse (Magnisense 201511 CEO) | Chief Executive Officer (CEO) | ||
| Selak, Sanya (Origimm Biotechnology 202112 CEO + CSO + Founder) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Serrano-Berntsen, Erik (Stable Asset Management 202207 CEO + Founder) | Chief Executive Officer (CEO) | Stable Asset Management | |
| Shelver, Graham (908 Devices 201507– Commercial Leader before Scion Instruments + Bruker) | Chief Commercial Officer (CCO) | Bruker (Group) | |
| Shiver, John (Sanofi 201607 SVP RnD at Sanofi Pasteur before Merck US 200506) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Singh, Amar (FMC 202107 Managing Director of FMC Ventures) | Managing Director | FMC (Group) | |
| Triomphe, Thomas (Sanofi 202112 EVP Global Head of Sanofi Pasteur) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Vert, Jean-Philippe (Bioptimus 202402 CEO + Co-Founder before Owkin + Google Brain) | Chief Executive Officer (CEO) | ||
| Weinand, Dieter (Sanofi 201811– Head Primary Care Unit before Bayer + Otsuka + Pfzer + BMS) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Weiner, Aaron (Coatue Management 202110 Managing Director + Head of Healthcare) | Managing Director | Coatue Management | |
| Williams, Dave (Sanofi Pasteur 200702 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | |
| Yao, Zhizhong (Joel) (Sofinnova 202312 Partner in Biovelocita initiative) | Partner (venture partner) | ||
| Yu, Michael (Innovent Biologics 202208 CEO + Founder) | n. a. | ||
| Rax, Jean-François (Alscace (govt) 201812 Investment Manager at Cap Innov’Est) | Investment Manager | Capital Grand Est | Alsace (Elsass) (region) [before 2015] |
| Rutt, Antony (KDBio SAS 201704 President + Founder) | President/Director/Head Business Group/Unit/Division | KDBio SAS | Alsace (Elsass) (region) [before 2015] |
| Polukhtin, Andreï (Click Chemistry Tools 202001 Managing Director + Founder) | Managing Director | Click Chemistry Tools LLC | Arizona (federal state) |
| Abdellaoui, Hautman (RED Horticulture 202311 CFO) | Chief Financial Officer (CFO) | RED Horticulture (Rouge Engineered Designs) (Group) | Auvergne-Rhône-Alpes (region) |
| Abribat, Thierry (Alizé Pharma 2007– President + Founder) | Chief Executive Officer (CEO) | Alizé Pharma (Group) | Auvergne-Rhône-Alpes (region) |
| Affagard, Hervé (MaaT Pharma 201507 CEO) | Chief Executive Officer (CEO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Agostino-Etchetto, Florence (Lyonbiopole 201306– Managing Director joined 201209 before Hospices Civils de Lyon) | Cluster Manager | Lyonbiopôle | Auvergne-Rhône-Alpes (region) |
| Alberici, Gilles (Orega Biotech 201601 CEO before Octalfa 2009 President before OPi SA founder + president) | Chief Executive Officer (CEO) | Orega Biotech (FR) | Auvergne-Rhône-Alpes (region) |
| Altaba, Stéphane (LXRepair 202101– CEO before Genomic Vision + Nordic Pharma + Sanofi + Riken) | Chief Executive Officer (CEO) | LXRepair SAS | Auvergne-Rhône-Alpes (region) |
| Andréucci, Philippe (APIX 201302 VP Business Development + Co-founder) | Business Development Manager / Strategy Manager | Analytical Pixels Technology SAS (APIX) | Auvergne-Rhône-Alpes (region) |
| Archinard, Philippe (Institu Mérieux 202101– EVP Technological Innovation + Scientific Partnerships before Transgene) | Chief Executive Officer (CEO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Attuil, Valérie (Mablink Bioscience 202104 COO) | Chief Operating Officer (COO) | Eli Lilly (Group) | Auvergne-Rhône-Alpes (region) |
| Audebert, Benjamin (Carbios 201601 Investor Relations) | Public Relations Manager / Investor Relations Manager | Carbios (Group) | Auvergne-Rhône-Alpes (region) |
| Aurore, Sergeant (Mérieux 201302– Head of Corporate Communications at bioMérieux joined 4/11) | Public Relations Manager / Investor Relations Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Baguenault, Michel (Mérieux 201608 Secretary General at bioMérieux) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bastid, Jérémy (Orega Biotech 201601 COO) | Chief Operating Officer (COO) | Orega Biotech (FR) | Auvergne-Rhône-Alpes (region) |
| Baum, Binah (Alma Bio Therapeutics 201706 CEO + Co-Founder) | Chief Executive Officer (CEO) | Alma Bio Therapeutics S.A.S | Auvergne-Rhône-Alpes (region) |
| Bélingard, Jean-Luc (Mérieux 201101– Président Directeur Général before Ipsen CEO + Pierre Fabre + Roche Diagnostics) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bernal, Savita (MaaT Pharma 202005– CBO before Adocia + e(ye)BRAIN + Ernst & Young Paris) | Chief Business Officer (CBO) | MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT) | Auvergne-Rhône-Alpes (region) |
| Bertaïna, Frédéric (Bioxis Pharmaceuticals 202005 CEO) | Chief Executive Officer (CEO) | Bioxis Pharmaceuticals SAS | Auvergne-Rhône-Alpes (region) |
| Berteletti, Alexandre (Leman Instruments 201706) | n. a. | Leman Instruments SAS | Auvergne-Rhône-Alpes (region) |
| Binant, Étienne (Biom’Up 201509 CEO) | Chief Executive Officer (CEO) | Biom’Up S.A. (Euronext: BUP) | Auvergne-Rhône-Alpes (region) |
| Blanc, Manuel (Lys Therapeutics 202303 CEO + Co-Founder) | Chief Executive Officer (CEO) | Lys Therapeutics SAS | Auvergne-Rhône-Alpes (region) |
| Blanc-Michaud, Annick (Mérieux 201210 bioMérieux) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Boissel, François-Henri (Novadiscovery 201811 CEO + Co-Founder) | Chief Executive Officer (CEO) | Novadiscovery (FR) | Auvergne-Rhône-Alpes (region) |
| Boissel, Pascale (Enyo Pharma 201705– CFO before BIOASTER + Ipsogen) | Chief Financial Officer (CFO) | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Bonnamour, Yoann (Mérieux 202012 Associate at Mérieux Equity Partners) | Investment Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bonnefoy, Jean-Yves (Anangesis 201606 CEO before ElsaLys 201305– CEO + Co-founder before Transgene) | Chief Executive Officer (CEO) | Mediolanum (Group) | Auvergne-Rhône-Alpes (region) |
| Bonneville, Christophe (Resolution Spectra Systems 202007 President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Merck (DE) (Group) | Auvergne-Rhône-Alpes (region) |
| Boulud, Pierre (Mérieux 202310 CEO of bioMèrieux joined 11/16 before Ipsen + Boston Consulting + Bossard Consultants) | Chief Executive Officer (CEO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bozza, Aurélie (Poxel 202005 Investor Relations + Communications Director) | Public Relations Manager / Investor Relations Manager | Poxel (Group) | Auvergne-Rhône-Alpes (region) |
| Bravetti, Paul (Brenus Pharma 202301 CEO) | Chief Executive Officer (CEO) | Brenus Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Brechot, Christian (Institut Mérieux 201008 Vice President) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Bricout, Pascal (Carbios 202209– Chief Strategy + Financial Officer before Michelin in Asia) | Chief Financial Officer (CFO) | Carbios (Group) | Auvergne-Rhône-Alpes (region) |
| Brochette, Hervé (Weezion 202205 CEO + Co-Founder) | Chief Executive Officer (CEO) | Weezion SAS | Auvergne-Rhône-Alpes (region) |
| Bronstein, Liliane (ElsaLys 201701– VP Finance) | Chief Financial Officer (CFO) | Mediolanum (Group) | Auvergne-Rhône-Alpes (region) |
| Brun, Virginie (PX'Therapeutics 201008– CSO + co-founder of Promise Advanced Proteomics) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Aguettant (Group) | Auvergne-Rhône-Alpes (region) |
| Böhmer Christoph (ArchiMed 201609 Operating Partner before McKinsey + Biotronik) | Investment Manager | ArchiMed (Group) | Auvergne-Rhône-Alpes (region) |
| Calenda, Valérie (Mérieux 201604 Partner at Mérieux Développement) | Partner (venture partner) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Cartier, Nicolas (Mérieux 201305– Corporate VP Industrial Microbiology Unit at bioMérieux before Sanofi France) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Cavert, Denis (Vaxxel 202004 President + Co-Founder) | Chief Executive Officer (CEO) | Vaxxel SAS | Auvergne-Rhône-Alpes (region) |
| Charvériat, Mathieu (Theranexus 201904 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Theranexus S.A. (Euronext Growth: ALTHX) | Auvergne-Rhône-Alpes (region) |
| Chastaing, Benoît (Mérieux 202012 Managing Partner at Mérieux Equity Partners) | Managing Partner (investment firm) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Chatelain, Francois (Cytoo 201109 CEO) | Chief Executive Officer (CEO) | Cytoo (Group) | Auvergne-Rhône-Alpes (region) |
| Chevrillon, Romain (Mérieux 2019– Associate at Mérieux Equity Partners) | n. a. | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Chlasta, Julien (BioMeca 201802 President + Co-Founder) | President/Director/Head Business Group/Unit/Division | BioMeca (FR) | Auvergne-Rhône-Alpes (region) |
| Clancy, Annette (Enyo Pharma 201806 Chair of Board of Directors) | Board member, non-executive | Enyo Pharma S.A. | Auvergne-Rhône-Alpes (region) |
| Cleiftie, Jean-Sébastien (Erytech 201610– CBO before Sanofi + Innoven Partners + Aventis) | Chief Business Officer (CBO) | Erytech (Group) | Auvergne-Rhône-Alpes (region) |
| Contamin, Hugues (Cynbiose 201801 CEO) | Chief Executive Officer (CEO) | Cynbiose (Group) | Auvergne-Rhône-Alpes (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
